Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone ...

New research presented at the RSNA meeting suggests that levothyroxine, a common treatment for hypothyroidism, may contribute ...

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study ...

The researchers used the Baltimore Longitudinal Study of Aging, a prospective cohort study of community-dwelling older adults.

Levothyroxine — marketed under brand names such as Synthroid — is the second-most commonly prescribed medication among older adults in the US. It’s consumed by about 7% of the US population.

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old ...